Dr Brendan Cronin · Research
Dr Cronin has 17 publications in peer-reviewed journals, covering keratoconus, CAIRS, corneal cross-linking, cataract and glaucoma surgery, the ocular surface and corneal regeneration. He has also written 9 professional education articles for optometrists and other clinicians. Each entry below has a short note on what the work showed and why it matters for patients' vision.
Research profiles: Google Scholar · ORCID · PubMed
Original research, reviews and published correspondence in peer-reviewed ophthalmology and science journals, newest first.
2026
Clin Exp Ophthalmol. 2026; 54(5): 664-677
Introduced the Brisbane nomogram for planning femtosecond laser CAIRS, which improved uncorrected vision by an average of four lines and gives surgeons worldwide a reproducible way to reshape keratoconic corneas.
2026
Clin Exp Ophthalmol. 2026; doi:10.1111/ceo.70166
Correspondence
Responded to published correspondence on the Brisbane nomogram, addressing both the technical promise of femtosecond CAIRS and the responsible stewardship of donated corneal tissue.
2026
Clin Exp Ophthalmol. 2026; doi:10.1111/ceo.70193
Correspondence
Continued the published scientific debate on the Brisbane nomogram, the open scrutiny that keeps new keratoconus treatments safe and well understood.
2025
Cornea. 2025; 10.1097/ICO.0000000000003853
Described a way to perform CAIRS without a femtosecond laser, opening this keratoconus treatment to surgeons and patients in places without the expensive equipment.
2024
J Cataract Refract Surg. 2024; 50(3):209-216
In 102 eyes, topography-guided epithelium-on cross-linking stabilised keratoconus, flattened the cone and improved corrected vision in 60% of patients.
2024
Eye. 2024; 10.1038/s41433-024-03039-8
Measured quality of vision with a new fully refractive extended depth of focus lens, helping cataract patients make informed choices about lenses that extend their range of vision.
2022
J Cataract Refract Surg. 2022; 10.1097/j.jcrs.0000000000000952
Reported one-year results of oxygen-supplemented epithelium-on cross-linking, a gentler way to stabilise keratoconus without removing the surface of the cornea.
2021
J Glaucoma. 2021; 30:192-194
Reported outcomes of the Hydrus microstent in patients who had already had cataract surgery, extending a minimally invasive option to people whose glaucoma was uncontrolled on drops.
2020
Clin Ophthalmol. 2020; 14:2291-2300
Evaluated a new preloaded lens injector in routine cataract surgery, supporting a cleaner, more consistent way to place the lens implant in patients' eyes.
2018
Ophthalmic Plast Reconstr Surg. 2018; 34(5):477-482
Tested whether light-activated cross-linking can stiffen the eyelid's tarsal plate, pointing towards a possible non-surgical treatment for floppy, lax eyelids.
2017
Clin Exp Ophthalmol. 2017; 45(2):174-181
Mapped how often severe limbal stem cell deficiency occurs across Australia and New Zealand and what causes it, evidence that shapes care for people at risk of corneal blindness.
2016
Cornea. 2016; 35(8):1127-31
Used confocal microscopy to identify goblet cells within pterygium, deepening understanding of this common sun-related growth on the surface of the eye.
2016
Exp Eye Res. 2016; 147:1-11
Developed a reliable laboratory model of ocular surface failure, a necessary step in testing new stem cell therapies for people blinded by surface disease.
2015
Stem Cells. March 2015;33(3):785-91
Systematically reviewed whether mesenchymal stromal cells can become corneal cells, a key question for growing corneal tissue in the lab instead of relying on donor corneas.
2010
Eye February 2010; 24 : 315-317
Compared the astigmatism left by 20- and 25-gauge vitrectomy incisions, giving retinal surgeons evidence on how incision size affects the sharpness of patients' vision afterwards.
2007
Aust Fam Physician. 2007; 36(10) : 831-2
Alerted GPs that a red eye in a contact lens wearer is a high-risk presentation that can hide a sight-threatening corneal infection.
2005
Int Ophthalmol. 2005; 26(3) : 101-5
Reported an association between tamoxifen breast cancer therapy and macular holes, helping doctors recognise a treatable cause of central vision loss in women taking the drug.
Articles written for optometrists, GPs and other clinicians in professional publications, newest first.
2026
MiVision February 2026
Updated optometrists on modern partial-thickness corneal transplants, which give patients faster recovery and a lower rejection risk than traditional full-thickness grafts.
2024
MiVision, June 2024
Explained how measuring corneal strength improves laser eye surgery screening, helping protect people whose corneas look normal but are biomechanically weak.
2023
MiVision, 1 April 2023
Explained the inflammatory cycle behind dry eye for optometrists, supporting treatment that breaks the cycle rather than masking the symptoms.
2023
MiVision, 3 July 2023
Gave optometrists a practical guide to spotting keratoconus early, while cross-linking can still preserve a patient's vision.
2022
Insight News, November 2022 46-48
Made the case for optometrists and corneal surgeons sharing keratoconus care, so young patients are diagnosed and treated before their vision is lost.
2020
MiVision, 17 January 2020
Explained minimally invasive glaucoma surgery to optometrists, helping patients reach safer, earlier surgical options that can reduce their reliance on drops.
2020
MiVision, 4 May 2020
Guided optometrists on treating the inflammation that drives dry eye disease, so patients get treatment aimed at the cause rather than lubricating drops alone.
2015
Pharma, March 2015
Explained how cataract surgery interacts with glaucoma, so clinicians can better support patients managing both conditions at once.
2014
Pharma, December 2014
Introduced intense pulsed light as a treatment for the oil-gland dysfunction behind most dry eye, a new option for patients whose drops weren't enough.
